Interpretable Machine Learning for Characterization of Focal Liver Lesions by Contrast-Enhanced Ultrasound
- PMID: 35320099
- PMCID: PMC9188683
- DOI: 10.1109/TUFFC.2022.3161719
Interpretable Machine Learning for Characterization of Focal Liver Lesions by Contrast-Enhanced Ultrasound
Abstract
This work proposes an interpretable radiomics approach to differentiate between malignant and benign focal liver lesions (FLLs) on contrast-enhanced ultrasound (CEUS). Although CEUS has shown promise for differential FLLs diagnosis, current clinical assessment is performed only by qualitative analysis of the contrast enhancement patterns. Quantitative analysis is often hampered by the unavoidable presence of motion artifacts and by the complex, spatiotemporal nature of liver contrast enhancement, consisting of multiple, overlapping vascular phases. To fully exploit the wealth of information in CEUS, while coping with these challenges, here we propose combining features extracted by the temporal and spatiotemporal analysis in the arterial phase enhancement with spatial features extracted by texture analysis at different time points. Using the extracted features as input, several machine learning classifiers are optimized to achieve semiautomatic FLLs characterization, for which there is no need for motion compensation and the only manual input required is the location of a suspicious lesion. Clinical validation on 87 FLLs from 72 patients at risk for hepatocellular carcinoma (HCC) showed promising performance, achieving a balanced accuracy of 0.84 in the distinction between benign and malignant lesions. Analysis of feature relevance demonstrates that a combination of spatiotemporal and texture features is needed to achieve the best performance. Interpretation of the most relevant features suggests that aspects related to microvascular perfusion and the microvascular architecture, together with the spatial enhancement characteristics at wash-in and peak enhancement, are important to aid the accurate characterization of FLLs.
Figures
Similar articles
-
Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.Swiss Med Wkly. 2019 Jun 30;149:w20087. doi: 10.4414/smw.2019.20087. eCollection 2019 Jun 17. Swiss Med Wkly. 2019. PMID: 31256416
-
A combined model based on radiomics features of Sonazoid contrast-enhanced ultrasound in the Kupffer phase for the diagnosis of well-differentiated hepatocellular carcinoma and atypical focal liver lesions: a prospective, multicenter study.Abdom Radiol (NY). 2024 Oct;49(10):3427-3437. doi: 10.1007/s00261-024-04253-4. Epub 2024 May 14. Abdom Radiol (NY). 2024. PMID: 38744698
-
Strategy for Accurate Diagnosis by Contrast-Enhanced Ultrasound of Focal Liver Lesions in Patients Not at High Risk for Hepatocellular Carcinoma: A Preliminary Study.J Ultrasound Med. 2023 Jun;42(6):1333-1344. doi: 10.1002/jum.16151. Epub 2022 Dec 19. J Ultrasound Med. 2023. PMID: 36534591
-
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160. Health Technol Assess. 2013. PMID: 23611316 Free PMC article. Review.
-
Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions.Clin Mol Hepatol. 2013 Mar;19(1):1-16. doi: 10.3350/cmh.2013.19.1.1. Epub 2013 Mar 25. Clin Mol Hepatol. 2013. PMID: 23593604 Free PMC article. Review.
Cited by
-
Advancing Hepatocellular Carcinoma Management Through Peritumoral Radiomics: Enhancing Diagnosis, Treatment, and Prognosis.J Hepatocell Carcinoma. 2024 Nov 4;11:2159-2168. doi: 10.2147/JHC.S493227. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39525830 Free PMC article. Review.
-
Interpretability-based machine learning for predicting the risk of death from pulmonary inflammation in Chinese intensive care unit patients.Front Med (Lausanne). 2024 Jun 12;11:1399527. doi: 10.3389/fmed.2024.1399527. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38933112 Free PMC article.
-
Diagnostic Performance of an Artificial Intelligence Model Based on Contrast-Enhanced Ultrasound in Patients with Liver Lesions: A Comparative Study with Clinicians.Diagnostics (Basel). 2023 Nov 5;13(21):3387. doi: 10.3390/diagnostics13213387. Diagnostics (Basel). 2023. PMID: 37958282 Free PMC article.
-
Artificial Intelligence in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review.J Clin Med. 2022 Oct 28;11(21):6368. doi: 10.3390/jcm11216368. J Clin Med. 2022. PMID: 36362596 Free PMC article. Review.
-
Artificial intelligence techniques in liver cancer.Front Oncol. 2024 Sep 3;14:1415859. doi: 10.3389/fonc.2024.1415859. eCollection 2024. Front Oncol. 2024. PMID: 39290245 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
